Govt Job: For M.Pharm, M.Sc, Ph.D Job at National Institute of Pathology | Pay upto Rs. 58,280 pm

The Indian Registry of Pathology was established in 1965 under the auspices of the Indian Council of Medical Research (ICMR) in New Delhi, India as a centre for the collection and distribution of teaching materials in pathology.

The Registry was renamed in 1980 as the National Institute of Pathology (IOP) in view of its expanded scope and activities.

As per the need of the post-independence era when a large number of new medical colleges were coming up, IRP took up the initiative with the original aims and objectives of collection, classification, duplication and distribution of a representative spectrum of histopathological teaching material to several medical colleges, institutions, individual pathologists and clinicians.

Post : Research Associate

Online applications are invited in the prescribed format up to 05:00 PM by February 18, 2022 for filling up the following temporary posts in the project entitled “A pre-clinical in vivo study for evaluating anti-Biofilm FDA approved drugs in reducing treatment duration of anti-TB drugs” on contractual basis at, ICMR-National Institute of Pathology, as per the details provided below. After screening of applications, only shortlisted applicants will be called for interview.

No of Post : One

Age Limit : 35 Years

Consolidated pay : @ Rs.58280 p.m. consolidated

Duration : 1 Year

Essential Qualifications : PhD or M.Sc/M.Pharma /M.Tech having 3 years research, teaching and design and development experience.

Desirable : PhD in Biological Sciences/Pharmacology, preference shall be given to candidates who have prior experience of handling laboratory animals as evident from research publications.

How to apply

Applications should reach by E-mail to tbprojectsnip@gmail.com latest by February 18, 2022.

Apply with detailed CV in the format provided in this advertisement. National Institute of Pathology (ICMR) reserves the right to shortlist the candidates in case of receipt of large number of applications.

Only Shortlisted candidates will be intimated by E-mail regarding the date and time of interview. All candidates must bring CV, original certificates, letter of recommendation, and one set of self-attested photocopy of all certificates.

Candidates who are already working elsewhere should provide NOC from current employer at the time of interview.

No TA/DA will be paid for attending the interview. The appointment is terminable with one month’s notice from either side.

The selected candidate will have no claim for regular appointment under ICMR or continuation of his/her services in any other project.

Related Posts

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…

Stem cell therapy for autism illegal: NMC advisory

New Delhi:  The National Medical Commission (NMC) issued a strict advisory on March 25, 2026, declaring stem cell therapy illegal for treating Autism Spectrum Disorder and cerebral palsy in routine…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha